SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2012 (unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months Ended March 31, 2012 and 2011 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By | 2016-02-05T03:13:40+00:00 May 15th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-8: (Original Filing)

[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]

By | 2016-03-01T04:44:36+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-8:

[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]

By | 2016-03-01T04:45:08+00:00 April 27th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-8: (Original Filing)

[PART I INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS PARTII INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3.orporation of Documents by Reference. The following documents areorporated by reference in this Registration Statement: (a) Thempanys Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with themmission on March 30, 2012;] [[Cozen OConnor Letterhead] April 27, 2012ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles oforporation and By-laws of thempany, each presently in effect; (ii) resolutions of thempanys Board of Directors] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-8 ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to thensolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2011.]

By | 2016-02-05T03:15:23+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-8: PART I INFORMATION REQUIRED IN THE SECTION 10(a)

[PART I INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS PARTII INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3.orporation of Documents by Reference. The following documents areorporated by reference in this Registration Statement: (a) Thempanys Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with themmission on March 30, 2012;] [[Cozen OConnor Letterhead] April 27, 2012ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles oforporation and By-laws of thempany, each presently in effect; (ii) resolutions of thempanys Board of Directors] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-8 ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to thensolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2011.]

By | 2016-02-05T03:16:18+00:00 April 27th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Item 5.07 Submission of Matters to a Vote of Security Holders On April 27, 2012,ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders. Set forth below are the matters voted upon at the meeting and the voting results: Proposal 1 Name Votes For Votes Withheld Weibing Lu 2,655,555]

By | 2016-02-05T03:17:17+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Item 5.07 Submission of Matters to a Vote

[Item 5.07 Submission of Matters to a Vote of Security Holders On April 27, 2012,ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders. Set forth below are the matters voted upon at the meeting and the voting results: Proposal 1 Name Votes For Votes Withheld Weibing Lu 2,655,555]

By | 2016-02-05T03:18:11+00:00 April 27th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar